Medicines for millions of patients

Literature Information

Publication Date 2021-11-11
DOI 10.1039/D1MD00279A
Impact Factor 0
Authors

David C. Rees


View Original

Abstract

In this opinion piece I share personal anecdotes from three drug discovery projects, sugammadex an anaesthetic reversal agent from Organon Scotland, and ribociclib and erdafitinib, both oncology drugs arising from Astex UK collaborations with Novartis and Janssen respectively. These drugs have been used to treat millions of patients. The learnings from this research focus on innovation, teamwork, and collaborations. Drug discovery, even with its frustrations and disappointments can be a great career for scientists in industry, in academia, or in a not-for-profit institute, who want their research to alleviate human suffering.

Related Literature

Competitive adsorption on gold nanoparticles for human papillomavirus 16 L1 protein detection by LDI-MS

Jing Han, Zhihua Wang, Lihui Yin, Wei Zhang, You Peng, Zongxiu Nie

2019-09-29 Paper

DOI: 10.1039/C9AN01612K

Back cover

Cover

DOI: 10.1039/C6AN90046A

Ambient electrospray deposition Raman spectroscopy (AESD RS) using soft landed preformed silver nanoparticles for rapid and sensitive analysis

Tripti Ahuja, Atanu Ghosh, Sandip Mondal, Pallab Basuri, Shantha Kumar Jenifer, Pillalamarri Srikrishnarka, Jyoti Sarita Mohanty, Sandeep Bose, Thalappil Pradeep

2019-10-15 Paper

DOI: 10.1039/C9AN01700C

Voltammetric detection of glutathione: an adsorptive stripping voltammetry approach

Madalena C. C. Areias, Kenichi Shimizu, Richard G. Compton

2016-04-01 Paper

DOI: 10.1039/C6AN00550K

Correction: Shell-isolated nanoparticle-enhanced Raman spectroscopy study of the adsorption behaviour of DNA bases on Au(111) electrode surfaces

Bao-Ying Wen, Xi Jin, Yue Li, Ya-Hao Wang, Chao-Yu Li, Miao-Miao Liang, Rajapandiyan Panneerselvam, Qing-Chi Xu, De-Yin Wu, Zhi-Lin Yang, Jian-Feng Li, Zhong-Qun Tian

2016-04-15 Correction

DOI: 10.1039/C6AN90033J

Enzymatic reaction-based nanopore detection of zinc ions

Golbarg Mohammadi Roozbahani, Youwen Zhang, Xiaohan Chen, Mona Hoseini Soflaee, Xiyun Guan

2019-10-18 Paper

DOI: 10.1039/C9AN01784D

Front cover

Cover

DOI: 10.1039/C9AN90111F

You might also like

Compound Q&A

What are the main uses of (3alpha,5alpha)-3-Hydroxypregnane-11,20-dione (CAS: 23930-19-0)?

(3alpha,5alpha)-3-Hydroxypregnane-11,20-dione is primarily used in the pharmaceu...

23930-19-0(3alpha,5alpha)-3-Hy...
Compound Q&A

What is the market or research trend for 4-Amino-6-chloro-2-pyridinecarboxylic acid (CAS: 546141-56-4)?

The market for 4-Amino-6-chloro-2-pyridinecarboxylic acid (CAS: 546141-56-4) is ...

546141-56-44-Amino-6-chloro-2-p...
Compound Q&A

Are there alternatives to (2-Benzoylethyl)trimethylammonium chloride (CAS: 24472-88-6) in synthesis?

Alternatives to (2-Benzoylethyl)trimethylammonium chloride (CAS: 24472-88-6) in ...

24472-88-6(2-Benzoylethyl)trim...
Compound Q&A

Is N-[4-Nitro-3-(trifluoromethyl)phenyl]acetamide (CAS: 393-12-4) safe?

N-[4-Nitro-3-(trifluoromethyl)phenyl]acetamide (CAS: 393-12-4) is generally safe...

393-12-4N-[4-Nitro-3-(triflu...
Compound Q&A

Are there alternatives to N,N'-Bis(3-aminopropyl)-1,3-propanediamine (CAS: 4605-14-5) in synthesis?

There are alternatives to N,N'-Bis(3-aminopropyl)-1,3-propanediamine (CAS: 4605-...

4605-14-5N,N'-Bis(3-aminoprop...
Compound Q&A

What precautions should be taken when handling Aluminium trihexadecanoate (CAS: 555-35-1)?

When handling Aluminium trihexadecanoate, it is important to use appropriate per...

555-35-1Aluminium trihexadec...
Compound Q&A

What is (1,1-Dioxido-3-oxo-1,2-benzothiazol-2(3H)-yl)acetic acid (CAS: 52188-11-1)?

(1,1-Dioxido-3-oxo-1,2-benzothiazol-2(3H)-yl)acetic acid is a chemical compound ...

52188-11-1(1,1-Dioxido-3-oxo-1...
Compound Q&A

Are there alternatives to 5,5-dimethyloxolan-2-one (CAS: 3123-97-5) in synthesis?

Several alternatives to 5,5-dimethyloxolan-2-one (CAS: 3123-97-5) can be used in...

3123-97-55,5-dimethyloxolan-2...
Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.